March 20, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that additional data from the Company’s Phase 1/1b ...
After hours: March 26 at 7:31:01 PM EDT Loading Chart for CRVS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback